TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

CombiMatrix Corp (NASDAQ:CBMX) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties Announced

  • If you purchased shares of CombiMatrix Corp (NASDAQ:CBMX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
CombiMatrix Corp
Security
NASDAQ: CBMX

Summary

May 12, 2017 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of CombiMatrix Corp (NASDAQ:CBMX) was announced over potential breaches of fiduciary duties by certain officers and directors at CombiMatrix.

The investigation by a law firm concerns whether certain CombiMatrix Corp directors breached their fiduciary duties.

Irvine, CA based CombiMatrix Corporation is a provider of molecular diagnostic solutions that specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. CombiMatrix Corp reported that its annual Total Revenue rose from $10.09 million in 2015 to $12.87 million in 2016 and that its Net Loss declined from $6.60 million in 2015 to $4.14 million in 2016.

Shares of CombiMatrix Corp (NASDAQ:CBMX) grew from $2.20 per share in November 2016 to as high as $6.40 per share on May 8, 2017.

Start Monitoring Your Investments